Universitätsklinikum Schleswig-Holstein (UKSH)

Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study—lessons learnt, baseline demographics and clinical characteristics (2026) Brittain G, Buckley E, Lanfranchi V, Long M, Tsaktanis T, Rothhammer V, Hansen C, et al. Journal article Association between psychosocial factors and adverse effects of light-to-moderate ambient heat in patients with chronic diseases: results of the prospective cohort study CLIMATE-II (2026) Schäfer I, Paucke V, Nothacker J, Menzel A, Döpfmer S, Hager K, Hueber S, et al. Journal article DNA methylation analysis of NOTCH1 variants reveals the first episignature for non-syndromic congenital heart defects (2026) Dombrowsky G, van der Laan L, Silva A, Breckpot J, Audain E, Wilsdon A, Levy MA, et al. Journal article Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article External quality assessment in antimicrobial susceptibility testing (EUCAST disc diffusion methodology) of five anaerobic strains – performance of 35 laboratories in Germany and Austria, 2024 (2026) Buhl M, Jung J, Stingu CS, Copsey-Mawer S, Held J, Haase G, Sieg M, et al. Journal article The future of clinical trials? Monitoring mobility as an outcome measure in Parkinson's disease: The mobilise-D study (2026) Yarnall AJ, Alcock L, Schlenstedt C, Armengol C, Becker C, Brown P, Buekers J, et al. Journal article PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype (2026) Stasik S, Eckardt JN, Röllig C, Baldus CD, Serve H, Müller-Tidow C, Schäfer-Eckart K, et al. Journal article Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy (2026) Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, et al. Journal article Drug-Drug Interactions as a Challenge in the Monotherapy of Advanced or Metastatic Clear-Cell Renal Cell Carcinoma with VEGFR-Associated Tyrosine Kinase Inhibitors Arzneimittelinteraktionen als Herausforderung bei der Monotherapie des fortgeschrittenen oder metastasierten klarzelligen Nierenzellkarzinoms mit VEGFR-assoziierten Tyrosinkinase-Inhibitoren (2026) Reinbold H, Goebell P, Merseburger AS Journal article, Review article Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis (2026) Geidel G, Bänsch S, Adam L, Fekade N, Rünger A, Zell T, Smit DJ, et al. Journal article